The chief executive and medical officers of Cytovia Therapeutics discussed the company's therapeutic targets and cell therapy scaffold.
Daniel Teper, PharmD, MBA
Advertisement
Cofounder and chief executive officer, Cytovia Therapeutics
Articles by Daniel Teper, PharmD, MBA
The chief executive and medical officers of Cytovia Therapeutics discussed their natural killer cell therapy technology.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
2
Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks
3
CGTLive®’s Weekly Rewind – October 17, 2025
4
